Breadth, phenotype and functionality of Gag-specific T cell responses induced by a heterologous DNA/MVA prime-boost HIV-1 vaccine regimen

Breadth, phenotype and functionality of Gag-specific T cell responses induced by a heterologous DNA/MVA prime-boost HIV-1 vaccine regimen

Bibliographic Details
Main Authors:	Podola L, Bauer A, Haule A, Sudi L, Nilsson C, Godoy-Ramirez K, Mann P, Missanga M, Kaluwa B, Maboko L, Lueer C, Mwakatima M, Aboud S, Bakari M, Currier J, Robb M, McCormack S, Joseph S, Lyamuya E, Hoelscher M, Wahren B, Sandström E, Biberfeld G, Geldmacher C, Kroidl A
Format:	Article
Language:	English
Published:	BMC 2012-09-01
Series:	Retrovirology

Similar Items

Preferential targeting of conserved Gag regions after vaccination with a heterologous DNA prime Modified Vaccinia Ankara boost HIV vaccine regime
by: Bauer A, et al.
Published: (2012-09-01)

Priming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: a phase IIa randomized clinical trial.
by: Patricia J Munseri, et al.
Published: (2015-01-01)

Priming with a “simplified regimen” of HIV-1 DNA vaccine is as good as a “standard regimen” when boosted with heterologous HIV-1 MVA vaccine
by: Munseri P, et al.
Published: (2012-09-01)

High prevalence of ECG variations and abnormalities in young and healthy TaMoVac 01 HIV vaccine trial volunteers from Tanzania
by: Mann PJ, et al.
Published: (2012-09-01)

Boosting with Subtype C CN54rgp140 Protein Adjuvanted with Glucopyranosyl Lipid Adjuvant after Priming with HIV-DNA and HIV-MVA Is Safe and Enhances Immune Responses: A Phase I Trial.
by: Agricola Joachim, et al.
Published: (2016-01-01)

Optimizing the immunogenicity of HIV prime-boost DNA-MVA-rgp140/GLA vaccines in a phase II randomized factorial trial design.
by: Edna O Viegas, et al.
Published: (2018-01-01)

Antibody-mediated inhibition of HIV-1 elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults
by: Joachim A, et al.
Published: (2012-09-01)

Induction of Identical IgG HIV-1 Envelope Epitope Recognition Patterns After Initial HIVIS-DNA/MVA-CMDR Immunization and a Late MVA-CMDR Boost
by: Agricola Joachim, et al.
Published: (2020-04-01)

Potent functional antibody responses elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults.
by: Agricola Joachim, et al.
Published: (2015-01-01)

Frequent and Durable Anti-HIV Envelope VIV2 IgG Responses Induced by HIV-1 DNA Priming and HIV-MVA Boosting in Healthy Tanzanian Volunteers
by: Agricola Joachim, et al.
Published: (2020-11-01)

Frequent Anti-V1V2 Responses Induced by HIV-DNA Followed by HIV-MVA with or without CN54rgp140/GLA-AF in Healthy African Volunteers
by: Frank Msafiri, et al.
Published: (2020-11-01)

P14-14 LB. A low dose of multigene, multiclade HIV DNA given intradermally induces strong and broad immune responses after boosting with heterologous HIV MVA
by: Wahren B, et al.
Published: (2009-10-01)

OA04-02. Strong HIV-specific CD4 and CD8 T-lymphocyte proliferation in HIV-1 DNA prime/modified vaccinia virus Ankara (MVA) heterologous boost vaccinees
by: Biberfeld G, et al.
Published: (2009-10-01)

Low specificity of determine HIV1/2 RDT using whole blood in south west Tanzania.
by: Inge Kroidl, et al.
Published: (2012-01-01)

Priming with Recombinant BCG Expressing HTI Enhances the Magnitude and Breadth of the T-Cell Immune Responses Elicited by MVA.HTI in BALB/c Mice
by: Narcís Saubi, et al.
Published: (2020-11-01)

Percutaneous Vaccination as an Effective Method of Delivery of MVA and MVA-Vectored Vaccines.
by: Clement A Meseda, et al.
Published: (2016-01-01)

Experiences of social harm and changes in sexual practices among volunteers who had completed a phase I/II HIV vaccine trial employing HIV-1 DNA priming and HIV-1 MVA boosting in Dar es Salaam, Tanzania.
by: Edith A M Tarimo, et al.
Published: (2014-01-01)

Increased breadth of HIV-1 neutralization achieved by diverse antibody clones each with limited neutralization breadth.
by: Valentine U Chukwuma, et al.
Published: (2018-01-01)

Trichuris trichiura infection and its relation to environmental factors in Mbeya region, Tanzania: A cross-sectional, population-based study.
by: Kirsi M Manz, et al.
Published: (2017-01-01)

P19-58 LB. Comparison of the immunogenicity in humans and rhesus macaques of vaccines consisting of DNA priming and MVA boosting and MVA priming and boosting
by: Wyatt LS, et al.
Published: (2009-10-01)

IL-12 and GM-CSF in DNA/MVA immunizations against HIV-1 CRF12_BF Nef induced T-cell responses with an enhanced magnitude, breadth and quality.
by: Ana María Rodríguez, et al.
Published: (2012-01-01)

Monitoring CD27 expression to evaluate Mycobacterium tuberculosis activity in HIV-1 infected individuals in vivo.
by: Alexandra Schuetz, et al.
Published: (2011-01-01)

The Breadth of the Riches
by: Sydnor Jon Paul
Published: (2016-04-01)

Large-sample hydrology: a need to balance depth with breadth
by: H. V. Gupta, et al.
Published: (2014-02-01)

Standards of head length and breadth for sardinian population (3-22 years)
by: E. Sanna, et al.
Published: (2012-11-01)

HIV-DNA Given with or without Intradermal Electroporation Is Safe and Highly Immunogenic in Healthy Swedish HIV-1 DNA/MVA Vaccinees: A Phase I Randomized Trial.
by: Charlotta Nilsson, et al.
Published: (2015-01-01)

Sex determination from distal epiphyseal breadth of tibia
by: Dangar K P, et al.
Published: (2015-03-01)

Definition of geographical breadth of district by the measuring of horizontal coordinates of the sun
by: O. M. Rachkovs’ky, et al.
Published: (2000-10-01)

Impact of dengue virus genetic diversity on breadth of neutralization by a tetravalent dengue vaccine
by: L. Karwal, et al.
Published: (2020-12-01)

Helminth-associated systemic immune activation and HIV co-receptor expression: response to albendazole/praziquantel treatment.
by: Mkunde Chachage, et al.
Published: (2014-03-01)

The role of MvaT in Pseudomonas aeruginosa
by: Worrall, Kathryn E.
Published: (2005)

EVA, MVA and Stock performance
by: Chun-hao Liu, et al.
Published: (2008)

The justification of breadth and balance in sixth form studies
by: Beck, A. W.
Published: (1977)

Evidence for Env-V2 sieve effect in breakthrough SIV <sub>MAC251</sub> infections in rhesus monkeys vaccinated with Ad26/MVA and MVA/Ad26 constructs
by: Sina S, et al.
Published: (2012-09-01)

American Handbooks of Music History: Breadth, Depth, and the Critique of Pedagogy
by: C. Matthew Balensuela
Published: (2015-12-01)

Mechanism of pyocyanin abolishment caused by mvaT mvaU double knockout in Pseudomonas aeruginosa PAO1
by: Limin Dong, et al.
Published: (2020-01-01)

The diversity and breadth of cancer cell fatty acid metabolism
by: Shilpa R. Nagarajan, et al.
Published: (2021-01-01)

On the breadth of dermal ridges in sardinians
by: G.U. Floris
Published: (2012-11-01)

Signaling in the phytomicrobiome: Breadth and Potential
by: Donald Lawrence Smith, et al.
Published: (2015-09-01)

The Breadth of Viruses in Human Semen
by: Alex P. Salam, et al.
Published: (2017-11-01)